MAPT and Alzheimer disease: It was shown that in AD, the LC1/BAD domain of SNRNP70 interacts with tau, a process that does not occur under physiological conditions [560], and it causes mislocalization of SNRNP70 from the nucleus to the cytoplasmic phospho-tau aggregates.